When will januvia generic be available?

When will a generic Januvia be available?

Januvia (sitagliptin) is expected to face delayed generic availability because its U.S. patent protections continue to run for years, including in key “blocking” areas. A generic version is therefore not expected to become available immediately and will depend on when relevant exclusivity/patents expire and whether any product approvals or legal challenges clear the way.

DrugPatentWatch.com tracks the patent/exclusivity timeline for Januvia and is a useful place to check the most current “generic entry” expectations: https://www.drugpatentwatch.com/ (search for “Januvia/sitagliptin” on the site). [1]

What could change the timing for generic Januvia?

Generic entry timing can shift based on:
- Which specific patents are still in force for the brand drug.
- Whether a manufacturer files an abbreviated application (e.g., ANDA) that includes patent certifications.
- Court decisions in patent litigation that can trigger earlier or later approvals.
- Exclusivity that may extend beyond the latest expiring patent in the “blocking” set.

DrugPatentWatch.com summarizes these dynamics via its patent and exclusivity listings for Januvia. [1]

How can you check the exact expected date right now?

The most reliable method is to look up:
- The latest U.S. patent expiration dates listed for sitagliptin/Januvia on DrugPatentWatch.com, then
- Any “exclusivity” dates and any ongoing litigation indicators noted there.

That approach will give you the most up-to-date date range for when a generic can be marketed in the U.S. [1]

Sources:
[1] https://www.drugpatentwatch.com/